AzTrials
AzTrials

Critical IllnessPSY-CO-ICUNCT04511780

Psychological Impact of COVID-19 Outbreak on Caregivers

An observational study of Critical Illness and Covid19, run by Centre Hospitalier Universitaire de Nīmes at 51 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Based on the experience of previous pandemics, countries reacted by applying different upgrade strategies to prevent or delay the widespread of the disease. Therefore, measures such as border closure, school closure, restrict social gathering (even shutdown of workplaces), limit population movements, and confinement… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
questionnaire filling
How many people
701 participants
Where
51 sitesFrance
Study dates
25 Feb 2021to 20 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak

Who may be able to join

  • Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak
  • Approved to participate

Who cannot join

  • Participation refusal
  • No internet connection for responding to the questionnaire with REDCAP file

Trial locations and contacts

51 sites in 1 country.

51 sites in 1 country

France51 sites
  • Intensive Care Unit, CHU d'Amiens

    Amiens, 80054

  • Intensive Care Unit, CHU d'Angers

    Angers, 49933

  • CHU de Besançon

    Besançon, 25030

  • CHU de Bordeaux, Hôpital Pellegrin

    Bordeaux, 33076

  • Intensive care Unit CHU de Brest Hôpital Cavale Blanche

    Brest, 29609

  • CHU de Caen

    Caen, 14033

  • CHU de Clermont Ferrand

    Clermont-Ferrand, 63003

  • AP-HP, Hôpital Henri Mondor

    Créteil, 94010

  • CHU de dijon

    Dijon, 21079

  • CHU de Grenoble, Hôpital Michalon

    La Tronche, 38700

  • AP_HP, Hôpital du Kremlin Bicêtre

    Le Kremlin-Bicêtre, 94275

  • Intensive Care Unit, CHRU de Lille

    Lille, 59037

  • Intensive Care Unit, CHU de Limoges

    Limoges, 87042

  • Hôpitaux civils de Lyon, Hôpital de la Croix Rousse

    Lyon, 69317

  • Hôpitaux civils de Lyon, Hôpital Louis Pradel

    Lyon, 69394

  • Hôpitaux civils de Lyon, Hôpital Edouard Herriot

    Lyon, 69437

  • AP-HM, Hôpital Nord

    Marseille, 13005

  • AP-HM, Hôpital Timone adultes, Intensive Care Unit

    Marseille, 13005

  • AP-HM, Hôpital Timone adultes, Neurotraumatology

    Marseille, 13015

  • AP-HM, Hôpital e la Conception

    Marseille, 13385

  • CHU de Montpellier, Hôpital Guy de chauliac

    Montpellier, 34295

  • CHU de Montpellier, Hôpital Lapeyronie

    Montpellier, 34295

  • CHU de Montpellier, Hôpital St Eloi SAR B

    Montpellier, 34295

  • CHU De Montpellier, Hôpital St Eloi-DAR B

    Montpellier, 34295

  • CHU De Montpellier, Hôpital St Eloi

    Montpellier, 34295

  • Intensive Care Unit, CHU de Mulhouse

    Mulhouse, 68051

  • Intensive CAre Unit CHRU de Nancy, Hôpital Central

    Nancy, 54000

  • Intensive Care Unit, CHU de Nantes, Hôtel Dieu

    Nantes, 44093

  • Intensive Care Unit, CHU de Nantes

    Nantes, 44093

  • CHU de Nice

    Nice, 06000

  • Intensive care Unit CHU Nîmes

    Nîmes, 30029

  • AP-HP, Hôpital de la Pitié

    Paris, 75013

  • AP-HP, Hôpital Bichât

    Paris, 75018

  • AP-HP, Hôpital Lariboisière

    Paris, 75475

  • AP6HP, Hôpital St Loui

    Paris, 75475

  • AP_HP, Hôpital G Pompidou

    Paris, 75908

  • AP-HP, Hôpital St Antoine

    Paris, 75970

  • CH de Perpignan

    Perpignan, 66046

  • CHU de Bordeaux, Hôpital Haut Leveque

    Pessac, 33604

  • Intensive care Unit, Hôpitaux civils de Lyon, Lyon Sud

    Pierre-Bénite, 69310

  • CHU de Poitiers

    Poitiers, 86021

  • Intensive care Unit CHU de Rennes

    Rennes, 35033

  • CHU de Rouen

    Rouen, 76031

  • CHU de St Etienne, Hôpital Nord

    Saint-Etienne, 42055

  • Intensive Care Unit, CHU de Nantes, Hôpital Laennec

    Saint-Herblain, 44800

  • Intesive Care Unit CHRU de Strasbourg, Hôpital civil

    Strasbourg, 67091

  • Intesive Care Unit CHRU de Strasbourg, Hôpital Hautepierre

    Strasbourg, 67098

  • CHU de Toulouse

    Toulouse, 31059

  • Intensive care unit CHU de Tours

    Tours, 37044

  • Intensive CAre Unit CHRU de Nancy, Hôpital de Brabois

    Vandœuvre-lès-Nancy, 54511

  • CH de Vesoul

    Vesoul, 70014

Other trials in France

About this study

Official title: Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome

Based on the experience of previous pandemics, countries reacted by applying different upgrade strategies to prevent or delay the widespread of the disease. Therefore, measures such as border closure, school closure, restrict social gathering (even shutdown of workplaces), limit population movements, and confinement meaning quarantines at the scale of cities or regions. In public hospitals, several measures have been decided to concentrate the power of care on potential wave of admissions of patients with severe forms of Covid-19. In this purpose, the number of available beds in Intensive Care Units (ICU) has been increased by two-fold and scheduled non-emergency surgical procedure have been cancelled. That means:

  1. For the most severe patients, new personals (physician such as anesthesiologists, nurses of other units) have been transferred in ICUs.
  2. For the less severe patients, personals of non-busy units have been transferred in busier ones.
Read more

All these measures lead to major daily-life change sets that could be stressful. In the general population, it has been well documented that quarantine or confinement or isolation could lead to the occurrence of Post-Traumatic Stress Disorder (PTSD) syndrome in about 30% overall population. Importantly, high depressive symptoms have been reported in 9% of hospital staff. Numerous symptoms have been reported after quarantine or isolation such as emotional disturbance, depression, stress, low mood, irritability, insomnia, and post-traumatic stress symptoms.

In hospital setting, few studies have been performed for assessing the psychological impact of quarantine and isolation. However, two studies reported a high prevalence of burn-out syndrome (BOS) in ICU physician and PTSD syndrome and depression in ICU nurses. As the consequences of all the measures decided and applied during Covid-19 pandemic could be important on caregivers, the present study primarily aims at assessing the prevalence of PTSD syndrome in a large population of caregivers implied or not in Intensive Care Units. The secondary objective were 1) to assess the prevalence of severe depression and anxiety and BOS 2) to isolate potential factors associated with PTSD, severe depression, anxiety or BOS.

Being tested
questionnaire filling
Medical subject headings
Critical Illness, COVID-19, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • questionnaire fillingOther

    assessment of post-traumatic stress, anxiety and burn out

Study groups in NCT04511780
Study groupRoleWhat they receive
Caregivers• Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak
Receives: Other: questionnaire filling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-Traumatic Stress Disorder

    PCL - 5 (Post-Traumatic Stress Disorder Checklist Scale, version DSM-5)

    Measured: 3-6 month after the Covid-19 outbreak

Secondary outcomes (2)
  1. anxiety and depression

    HADS scale (Hospital Anxiety and Depression Scale)

    Measured: 3-6 month after the Covid-19 outbreak

  2. Burn out

    Score MBI (Burn out syndrome)

    Measured: 3-6 month after the Covid-19 outbreak

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2020
  2. Study start25 Feb 2021
  3. Primary completion20 Jul 2022
  4. Study completion20 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
701 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04511780
Sponsor's protocol ID
Local/2020/JYL-03
Acronym
PSY-CO-ICU
Status last verified
Dec 2025
First submitted
12 Aug 2020
Last updated
10 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Roger C, Ling L, Petrier M, Elotmani L, Atchade E, Allaouchiche B, Aubrun F, Constantin JM, Dahyot-Fizelier C, Delhaye N, Dupont H, Fischer MO, Garnier M, Gayat E, Ichai C, Jaber S, Morel J, Plaud B, Rimmele T, Robin S, Saba R, Joynt GM, Lefrant JY, Fabbro-Peray P, Lipman J, Conejero I, Laupland K. Occurrences of post-traumatic stress disorder, anxiety, depression, and burnout syndrome in ICU staff workers after two-year of the COVID-19 pandemic: the international PSY-CO in ICU study. Ann Gen Psychiatry. 2024 Jan 3;23(1):3. doi: 10.1186/s12991-023-00488-5.

    PubMed 38172994

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness and Covid19, run by Centre Hospitalier Universitaire de Nīmes at 51 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 51 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-Traumatic Stress Disorder (time frame: 3-6 month after the Covid-19 outbreak). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04511780, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in